I-VIREX - Ukuhlolwa kwe-Dx kwesizukulwane esilandelayo ekhaya nge-PCR-level Sensitivity for Daily Covid-19 Tests kanye ne-Early Cancer Dx
Kuboniswe ukuzwela okuphezulu kakhulu kubahlaziyi bebhayoloji abaningi, okuhlanganisa:
- Ukutholwa kwegciwane le-COVID-19 kuzwela njenge-5 TCID50, ephikisana nokuzwela kwe-PCR
- Ukuhlolwa kwe-biomarker yomdlavuza wesibindi kusenesikhathi kuthola i-protein biomarker eqondiwe kuma-microliters angu-5 egazi.
Ukuthuthukiswa kwamakhemikhali kanye ne-prototyping okulindeleke ukuthi kuqedwe ngo-Q3 2022 ngokuhlolwa kwenkambu ye-prototype ukuze kuhanjiswe ngokomthetho ku-Q3/Q4 2022.
Ngokuklama nokuhlinzeka okuthuthukiswe ngokugcwele kokuhlolwa kwesizukulwane sokuqala se-Virex Dx, umtapo wezincwadi we-GMAB wase-Sorrento uzosetshenziswa ukuze kuthuthukiswe ngokushesha futhi kuthunyelwe izivivinyo ezibucayi kakhulu ngokumelene nezifo eziningi ezithathelwanayo kanye nezinsongo ze-biologic.
Isiteji se-Virex sinikeza amandla okuthuthukisa ngokushesha izixazululo zokuhlola zokuxilonga zesizukulwane esilandelayo ezizwelayo kakhulu, ezithengekayo nezingalawuleki ze-COVID-19 nangale kwalokho ngokusebenzisa amakhemikhali nengqalasizinda yamamitha kashukela nemicu yokuhlola.
